We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Thermo Fisher Scientific to Showcase Anatomical Pathology Applications

By LabMedica International staff writers
Posted on 12 Sep 2011
Print article
Image:  The Cryostar NX70 Cryostat (Photo courtesy of Thermo Fisher Scientific).
Image: The Cryostar NX70 Cryostat (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific (Runcorn, United Kingdom) will display its latest anatomical pathology solutions at the Institute of Biomedical Science (IBMS) Congress 2011 to be held at the International Convention Center (ICC) Birmingham from September 26-28, 2011.

The anatomical pathology solutions to be exhibited include the Thermo Scientific next generation STP 420ES tissue processor, the Cryostar NX70 cryostat, and SecureSette tissue embedding cassettes.

The latest STP 420ES tissue processor is suitable for high-throughput tissue processing. It enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual-chamber design, which features rotational agitation that increases flow of traditional reagents by sevenfold to reduce processing times, the STP 420ES can process up to 420 cassettes per run. Holding 360 and 60 cassettes in the first and second chambers respectively, the second chamber allows independent processing of stat samples, as well as special or difficult tissues, without disrupting routine workflow or requiring the use of a second instrument.

The new CryoStar NX70 Cryostat offers better sectioning quality and increased user comfort. It accommodates a wide range of cryotomy applications for both clinical and research use. Its special features include rapid response temperature control and an innovative knife carrier feed to deliver precise section thickness and consistency.

The Thermo Scientific SecureSette tissue cassette enables lean workflow and enhances patient safety. Orientation is maintained throughout tissue processing and embedding, which means that the cassette is not opened until the sample is embedded in paraffin and ready for sectioning.

Quick and reproducible instrument set-up is simple with the CryoStar NX70’s intuitive LCD display and electronic touch-screen, together with joystick control. Fine adjustment specimen orientation on all axes enables fast and easy specimen alignment. The innovative temperature control system adjusts quickly to changes in settings, enabling rapid cooling, as well as consistent and precise temperature control. Three user-defined favorites enable frequently used temperature settings to be instantly recalled.

During the IBMS congress, Thermo Fisher will also demonstrate products from its immunohistochemistry (IHC) range, including the Thermo Scientific Autostainer and Quanto Reagents. These products offer rapid turnaround times and a flexible, total IHC workflow solution. In addition, PrintMate and SlideMate, the latest additions to Thermo Fisher's slide labeling and tracking product ranges will be presented.

Related Links:
Thermo Fisher Scientific
Institute of Biomedical Science
Institute of Biomedical Science Congress


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.